Teladoc Health, Inc. (TDOC) Financial Statements (2023 and earlier)
Company Profile
Business Address |
2 MANHATTANVILLE ROAD PURCHASE, NY 10577 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 896 | 787 | 517 | 424 | 122 | 66 | 137 | ||
Cash and cash equivalents | 893 | 733 | 514 | 424 | 43 | 50 | 55 | ||
Short-term investments | 3 | 53 | 3 | 79 | 16 | 82 | |||
Receivables | 169 | 169 | 57 | 44 | 27 | 14 | 12 | ||
Inventory, net of allowances, customer advances and progress billings | 73 | 56 | |||||||
Inventory | 73 | 56 | |||||||
Other undisclosed current assets | 87 | 47 | 14 | 65 | 7 | 3 | 2 | ||
Total current assets: | 1,225 | 1,060 | 588 | 533 | 156 | 83 | 152 | ||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 47 | 47 | 26 | ✕ | ✕ | ✕ | ✕ | ||
Property, plant and equipment | 27 | 29 | 10 | 10 | 9 | 7 | 6 | ||
Intangible assets, net (including goodwill) | 16,414 | 16,602 | 972 | 985 | 658 | 213 | 72 | ||
Goodwill | 14,504 | 14,581 | 746 | 737 | 499 | 188 | 56 | ||
Intangible assets, net (excluding goodwill) | 1,910 | 2,021 | 225 | 247 | 160 | 25 | 15 | ||
Other noncurrent assets | 21 | 18 | 7 | 1 | 1 | 0 | 0 | ||
Total noncurrent assets: | 16,509 | 16,696 | 1,015 | 996 | 668 | 221 | 78 | ||
TOTAL ASSETS: | 17,735 | 17,755 | 1,603 | 1,529 | 824 | 304 | 230 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 166 | 155 | 50 | 41 | 23 | 12 | 9 | ||
Accounts payable | 47 | 46 | 9 | 8 | 4 | 2 | 2 | ||
Accrued liabilities | 13 | 11 | 6 | 2 | 2 | 0 | 0 | ||
Employee-related liabilities | 92 | 95 | 31 | 28 | 17 | 9 | 6 | ||
Taxes payable | 13 | 2 | 3 | 3 | |||||
Interest and dividends payable | 1 | 2 | 1 | 1 | 0 | 0 | 0 | ||
Deferred revenue | 76 | 52 | 12 | ✕ | ✕ | ✕ | ✕ | ||
Debt | 43 | 5 | 2 | 1 | |||||
Restructuring reserve | 0 | 0 | 0 | ||||||
Estimated litigation liability | 2 | 1 | 1 | 1 | 1 | 1 | |||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 4 | 1 | 1 | ||
Contract with customer, liability | ✕ | ✕ | ✕ | 8 | ✕ | ✕ | ✕ | ||
Other liabilities | 30 | 21 | 8 | 3 | 5 | 2 | 2 | ||
Other undisclosed current liabilities | 59 | 60 | 14 | 9 | 8 | 3 | 3 | ||
Total current liabilities: | 331 | 333 | 90 | 62 | 40 | 21 | 18 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 1,267 | 1,423 | 465 | 415 | 207 | 42 | 25 | ||
Long-term debt, excluding current maturities | 1,226 | 1,380 | 440 | 415 | 207 | 42 | 25 | ||
Operating lease, liability | 42 | 43 | 25 | ✕ | ✕ | ✕ | ✕ | ||
Liabilities, other than long-term debt | 81 | 106 | 33 | 6 | 5 | 8 | 8 | ||
Deferred revenue | 4 | 2 | ✕ | ✕ | ✕ | ✕ | |||
Deferred tax liabilities, net | ✕ | ✕ | ✕ | 1 | |||||
Deferred income tax liabilities | 76 | 102 | 22 | ✕ | ✕ | ✕ | ✕ | ||
Other liabilities | 1 | 2 | 12 | 6 | 5 | 8 | 7 | ||
Total noncurrent liabilities: | 1,349 | 1,529 | 499 | 421 | 212 | 50 | 33 | ||
Total liabilities: | 1,680 | 1,862 | 589 | 483 | 253 | 71 | 51 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent | 16,046 | 15,884 | 1,014 | 1,013 | 559 | 231 | 179 | ||
Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Additional paid in capital | 17,473 | 16,858 | 1,539 | 1,435 | 866 | 436 | 309 | ||
Accumulated other comprehensive income (loss) | (6) | 19 | (17) | (13) | 4 | (0) | (0) | ||
Accumulated deficit | (1,421) | (993) | (508) | (409) | (312) | (205) | (131) | ||
Total stockholders' equity: | 16,046 | 15,884 | 1,014 | 1,013 | 559 | 231 | 179 | ||
Other undisclosed liabilities and equity | 9 | 10 | 32 | 13 | 2 | ||||
TOTAL LIABILITIES AND EQUITY: | 17,735 | 17,755 | 1,603 | 1,529 | 824 | 304 | 230 |
Income Statement (P&L) ($ in millions) Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 2,033 | 1,094 | 553 | 418 | 233 | 123 | 77 | |
Cost of revenue | (650) | (394) | (189) | (129) | (62) | (32) | (21) | |
Cost of goods and services sold | (650) | (391) | (184) | |||||
Gross profit: | 1,382 | 700 | 365 | 289 | 172 | 91 | 56 | |
Operating expenses | (1,648) | (1,206) | (445) | (322) | (225) | (142) | (107) | |
Other undisclosed operating loss | (38) | (22) | (11) | (5) | ||||
Operating loss: | (266) | (506) | (80) | (71) | (75) | (63) | (56) | |
Nonoperating income (Other Nonoperating income) | 5 | |||||||
Interest and debt expense | (44) | (9) | ||||||
Loss from continuing operations before equity method investments, income taxes: | (304) | (515) | (80) | (71) | (75) | (63) | (56) | |
Other undisclosed loss from continuing operations before income taxes | (80) | (60) | (29) | (26) | (32) | (11) | (2) | |
Loss from continuing operations before income taxes: | (385) | (576) | (109) | (97) | (107) | (74) | (58) | |
Income tax expense (benefit) | (44) | 91 | 11 | (0) | 0 | (1) | (0) | |
Net loss available to common stockholders, diluted: | (429) | (485) | (99) | (97) | (107) | (74) | (58) |
Comprehensive Income ($ in millions)Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (429) | (485) | (99) | (97) | (107) | (74) | (58) | |
Other comprehensive income (loss) | (25) | 36 | (4) | 0 | (0) | |||
Comprehensive loss: | (454) | (449) | (103) | (97) | (107) | (74) | (58) | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (17) | 4 | ||||||
Comprehensive loss, net of tax, attributable to parent: | (454) | (449) | (103) | (114) | (103) | (74) | (58) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.